Ethyl 2-(hydroxymethyl)acrylate (stabilized with HQ), 95.0%, 100g

4-(2-Piperidin-2-yl-ethyl)-morpholine, 95.0%, 1g

FLUMATINIB MESYLATE, 95%, 10mg

3-[(4-amino-6-oxo-1,6-dihydropyrimidin-2-yl)thio]propanoic acid, 95.0%, 1g

p-Tolylthiourea>98.0%(HPLC)5g

3-(difluoromethyl)-1,2-dihydropyridin-2-one, 95%, 5g

(S,E)-N-(4-((3,4-DIFLUOROPHENYL)AMINO)-7-((TETRAHYDROFURAN-3-YL)OXY)QUINAZOLIN-6-YL)-4-(DIMETHYLAMINO)BUT-2-ENAMIDE, 95%, 50mg

Phenyl propargyl ether, 97%, 10g

N-(3-methoxypropyl)-1-methyl-4-piperidinamine disuccinate, 95.0%, 5g

2-(4-FLUOROPHENYL)-6,7-DIHYDROPYRAZOLO[1,5-A]PYRAZIN-4(5H)-ONE, 95.0%, 500mg

2-[(4-amino-5-cyclohexyl-4h-1,2,4-triazol-3-yl)sulfanyl]acetic acid, 97%, 250mg

2,4-Dichloro-5-ethoxypyrimidine, 95.0%, 5g

Naphthalen-1-yl acetate, 99.0%, 5g